Drug-induced lupus.
Miyasaka
N
N
D000974:Antibodies, Antinuclear / Q000378:metabolism; D000927:Anticonvulsants / Q000009:adverse effects; D005013:Ethosuximide / Q000009:adverse effects; D005260:Female; D006801:Humans; D006830:Hydralazine / Q000009:adverse effects; D008180:Lupus Erythematosus, Systemic / Q000139:chemically induced* / Q000209:etiology / Q000276:immunology; D008297:Male; D011342:Procainamide / Q000009:adverse effects; D013577:Syndrome
D000974:Antibodies, Antinuclear; D000927:Anticonvulsants; D006830:Hydralazine; D005013:Ethosuximide; D011342:Procainamide